Nutrien Ltd.
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2025 · Filed Feb 27, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.3 · Share repurchase programs
Share repurchase programs
| Maximum · Maximum · Number of | |||||
|---|---|---|---|---|---|
| Commencement · shares for · shares for · shares | |||||
| date | Expiry | repurchase | repurchase (%) | repurchased | |
| 2023 Normal Course Issuer Bid | March 1, 2023 | February 29, 2024 | 24,962,194 | 5 | 5,375,397 |
| 2024 Normal Course Issuer Bid | March 1, 2024 | February 28, 2025 | 24,728,159 | 5 | 6,163,104 |
| 2025 Normal Course Issuer Bid | March 3, 2025 | March 2, 2026 | 24,462,941 | 5 | 7,611,207 |
| 2026 Normal Course Issuer Bid1 | March 3, 2026 | March 2, 2027 | 24,057,066 | 5 | ‐ |
1 On February 18, 2026, our Board of Directors approved a share repurchase program. The 2026 normal course issuer bid will expire earlier than the date above if we acquire the maximum number of common shares allowable or otherwise decide not to make any further repurchases.
Purchases under the normal course issuer bids were, or may be, made through open market purchases at market prices as well as by other means permitted by applicable securities regulatory authorities, including private agreements.
| Summary of share repurchases | 2025 | 2024 |
|---|---|---|
| Number of common shares repurchased for cancellation | 9,829,408 | 3,944,903 |
| Average price per share (US dollars) | 55.94 | 47.31 |
| Total cost, inclusive of tax | 560 | 190 |
Subsequent to December 31, 2025, as of February 17, 2026, an additional 1,097,694 common shares were repurchased for cancellation at a cost of $73 million and an average price per share of $66.97.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.